Sana Biotechnology Inc (NAS:SANA)
$ 6.91 -0.06 (-0.86%) Market Cap: 1.53 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 4.07 GF Score: 39/100

Sana Biotechnology Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 05:45PM GMT
Release Date Price: $5.16 (+1.48%)
Tessa Romero JPMorgan;Analyst

Welcome everyone to the 42nd Annual JPMorgan Healthcare Conference. My name is Tessa Romero, and I'm one of the senior biotechnology analysts here at JPMorgan. Our next presenting company is Sana and presenting on behalf of the company, we have CEO, Steve Harr. Steve?

Steve Harr Sana Biotechnology
Inc. - CEO

All right. Well, thank you, Tessa, and thank you, JPMorgan, for having us. Appreciate everybody in the audience who as I'm sure everybody recognizes will make a few forward-looking statements. So please do refer to our 10-Q. We spent a bunch of time running our risk factors for 2024 I think really promises to be an exciting and potentially translate, hopefully, transformative year for the company.

We spent a lot of 2023 preparing ourselves for a bunch of clinical data. And we at this time last year, we had no programs in clinical testing. Today, we have four across seven indications. We'll treat something like 40 to 60 patients in clinical studies this year, we'll have data available from every one of them.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot